vs

Side-by-side financial comparison of MEDIFAST INC (MED) and VIRCO MFG CORPORATION (VIRC). Click either name above to swap in a different company.

MEDIFAST INC is the larger business by last-quarter revenue ($75.1M vs $47.6M, roughly 1.6× VIRCO MFG CORPORATION). On growth, MEDIFAST INC posted the faster year-over-year revenue change (-36.9% vs -42.3%). VIRCO MFG CORPORATION produced more free cash flow last quarter ($24.5M vs $-6.6M). Over the past eight quarters, VIRCO MFG CORPORATION's revenue compounded faster (5.7% CAGR vs -34.4%).

Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.

The Virco Manufacturing Corporation, more commonly known as Virco, is an American furniture manufacturer based in Torrance, California which focuses on providing products for educational markets. The principal products of the company include student desks and activity tables, school and office seating, computer stations, lightweight folding tables, and upholstered chairs.

MED vs VIRC — Head-to-Head

Bigger by revenue
MED
MED
1.6× larger
MED
$75.1M
$47.6M
VIRC
Growing faster (revenue YoY)
MED
MED
+5.4% gap
MED
-36.9%
-42.3%
VIRC
More free cash flow
VIRC
VIRC
$31.2M more FCF
VIRC
$24.5M
$-6.6M
MED
Faster 2-yr revenue CAGR
VIRC
VIRC
Annualised
VIRC
5.7%
-34.4%
MED

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
MED
MED
VIRC
VIRC
Revenue
$75.1M
$47.6M
Net Profit
$-1.3M
Gross Margin
69.4%
38.0%
Operating Margin
-10.4%
-3.6%
Net Margin
-2.8%
Revenue YoY
-36.9%
-42.3%
Net Profit YoY
-115.8%
EPS (diluted)
$-1.64
$-0.08

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MED
MED
VIRC
VIRC
Q4 25
$75.1M
$47.6M
Q3 25
$89.4M
$92.1M
Q2 25
$105.6M
$33.8M
Q1 25
$115.7M
$28.5M
Q4 24
$119.0M
$82.6M
Q3 24
$140.2M
$108.4M
Q2 24
$168.6M
$46.7M
Q1 24
$174.7M
$42.6M
Net Profit
MED
MED
VIRC
VIRC
Q4 25
$-1.3M
Q3 25
$-2.3M
$10.2M
Q2 25
$2.5M
$732.0K
Q1 25
$-772.0K
$-5.7M
Q4 24
$8.4M
Q3 24
$1.1M
$16.8M
Q2 24
$-8.2M
$2.1M
Q1 24
$8.3M
$-2.3M
Gross Margin
MED
MED
VIRC
VIRC
Q4 25
69.4%
38.0%
Q3 25
69.5%
44.4%
Q2 25
72.6%
47.5%
Q1 25
72.8%
26.2%
Q4 24
74.1%
44.4%
Q3 24
75.4%
46.3%
Q2 24
73.2%
43.5%
Q1 24
72.8%
37.7%
Operating Margin
MED
MED
VIRC
VIRC
Q4 25
-10.4%
-3.6%
Q3 25
-4.6%
16.7%
Q2 25
-1.0%
-0.3%
Q1 25
-1.1%
-28.5%
Q4 24
0.6%
13.5%
Q3 24
1.5%
20.2%
Q2 24
-4.7%
6.4%
Q1 24
4.5%
-6.5%
Net Margin
MED
MED
VIRC
VIRC
Q4 25
-2.8%
Q3 25
-2.5%
11.1%
Q2 25
2.3%
2.2%
Q1 25
-0.7%
-20.1%
Q4 24
10.2%
Q3 24
0.8%
15.5%
Q2 24
-4.8%
4.6%
Q1 24
4.8%
-5.5%
EPS (diluted)
MED
MED
VIRC
VIRC
Q4 25
$-1.64
$-0.08
Q3 25
$-0.21
$0.65
Q2 25
$0.22
$0.05
Q1 25
$-0.07
$-0.37
Q4 24
$0.08
$0.52
Q3 24
$0.10
$1.04
Q2 24
$-0.75
$0.13
Q1 24
$0.76
$-0.14

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MED
MED
VIRC
VIRC
Cash + ST InvestmentsLiquidity on hand
$167.3M
Total DebtLower is stronger
$3.9M
Stockholders' EquityBook value
$198.9M
$113.6M
Total Assets
$248.0M
$181.5M
Debt / EquityLower = less leverage
0.03×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MED
MED
VIRC
VIRC
Q4 25
$167.3M
Q3 25
$173.5M
Q2 25
$162.7M
Q1 25
$164.6M
Q4 24
$162.3M
Q3 24
$170.0M
Q2 24
$163.5M
Q1 24
$156.4M
$5.3M
Total Debt
MED
MED
VIRC
VIRC
Q4 25
$3.9M
Q3 25
$4.0M
Q2 25
$4.1M
Q1 25
$4.1M
Q4 24
$4.2M
Q3 24
$4.3M
Q2 24
$7.0M
Q1 24
$4.4M
Stockholders' Equity
MED
MED
VIRC
VIRC
Q4 25
$198.9M
$113.6M
Q3 25
$214.7M
$115.4M
Q2 25
$216.0M
$105.6M
Q1 25
$211.0M
$109.3M
Q4 24
$210.1M
$115.9M
Q3 24
$207.3M
$107.8M
Q2 24
$205.3M
$91.6M
Q1 24
$211.0M
$91.2M
Total Assets
MED
MED
VIRC
VIRC
Q4 25
$248.0M
$181.5M
Q3 25
$268.2M
$198.6M
Q2 25
$269.3M
$183.8M
Q1 25
$280.0M
$191.9M
Q4 24
$284.2M
$210.1M
Q3 24
$291.2M
$216.3M
Q2 24
$293.5M
$152.5M
Q1 24
$302.8M
$146.4M
Debt / Equity
MED
MED
VIRC
VIRC
Q4 25
0.03×
Q3 25
0.03×
Q2 25
0.04×
Q1 25
0.04×
Q4 24
0.04×
Q3 24
0.04×
Q2 24
0.08×
Q1 24
0.05×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MED
MED
VIRC
VIRC
Operating Cash FlowLast quarter
$-5.3M
$25.8M
Free Cash FlowOCF − Capex
$-6.6M
$24.5M
FCF MarginFCF / Revenue
-8.8%
51.5%
Capex IntensityCapex / Revenue
1.8%
2.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$1.2M
$-4.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MED
MED
VIRC
VIRC
Q4 25
$-5.3M
$25.8M
Q3 25
$12.1M
$3.2M
Q2 25
$-3.4M
$-19.0M
Q1 25
$3.4M
$-8.3M
Q4 24
$-4.9M
$33.5M
Q3 24
$9.1M
$12.5M
Q2 24
$13.1M
$-4.5M
Q1 24
$7.3M
$4.7M
Free Cash Flow
MED
MED
VIRC
VIRC
Q4 25
$-6.6M
$24.5M
Q3 25
$10.8M
$1.8M
Q2 25
$-4.8M
$-21.5M
Q1 25
$1.9M
$-9.2M
Q4 24
$-7.2M
$31.0M
Q3 24
$7.7M
$10.7M
Q2 24
$11.1M
$-5.6M
Q1 24
$5.4M
$4.0M
FCF Margin
MED
MED
VIRC
VIRC
Q4 25
-8.8%
51.5%
Q3 25
12.0%
2.0%
Q2 25
-4.5%
-63.6%
Q1 25
1.6%
-32.4%
Q4 24
-6.1%
37.5%
Q3 24
5.5%
9.8%
Q2 24
6.6%
-12.0%
Q1 24
3.1%
9.5%
Capex Intensity
MED
MED
VIRC
VIRC
Q4 25
1.8%
2.7%
Q3 25
1.5%
1.5%
Q2 25
1.3%
7.2%
Q1 25
1.3%
3.3%
Q4 24
1.9%
3.0%
Q3 24
1.0%
1.7%
Q2 24
1.1%
2.3%
Q1 24
1.1%
1.5%
Cash Conversion
MED
MED
VIRC
VIRC
Q4 25
Q3 25
0.31×
Q2 25
-1.36×
-26.00×
Q1 25
Q4 24
3.98×
Q3 24
8.04×
0.74×
Q2 24
-2.11×
Q1 24
0.88×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons